Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate
- 1 June 1993
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2), 279-284
- https://doi.org/10.1111/j.1365-2141.1993.tb03065.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentratesBlood, 1992
- No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrateBritish Journal of Haematology, 1991
- Potential thrombogenicity of heat-treated prothrombin complex concentrates in Haemophilia BBlood Coagulation & Fibrinolysis, 1991
- Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrateBlood, 1990
- Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiencyBlood, 1988
- The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsBlood, 1982
- Activated clotting factors in factor IX concentratesBlood, 1979
- Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusionBlood, 1979
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974